April one, 2020 — Six months immediately after independent tests very first lifted the chance that well known heartburn drug ranitidine (Zantac) may well break down into the highly effective carcinogen n-nitrosodimethylamine (NDMA), the Food and drug administration has questioned for the removing of all ranitidine items from the current market. If you’re taking it now, halt.

“The agency has determined that the impurity in some ranitidine items raises more than time when saved at greater than space temperatures and might consequence in shopper exposure to unacceptable concentrations of this impurity,” the Food and drug administration mentioned in the announcement.